BRAF c.50C>A ;(p.A17D)

Variant ID: 7-140624454-G-T

NM_004333.4(BRAF):c.50C>A;(p.A17D)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer.

Nature Communications
Malagoli Tagliazucchi, Guidantonio G; Wiecek, Anna J AJ; Withnell, Eloise E; Secrier, Maria M
Publication Date: 2023-02-11

Variant appearance in text: BRAF: A17D
PubMed Link: 36774358
Variant Present in the following documents:
  • 41467_2023_36439_MOESM8_ESM.xlsx, sheet 49
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: BRAF: A17D
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



SeqOthello: querying RNA-seq experiments at scale.

Genome Biology
Yu, Ye Y; Liu, Jinpeng J; Liu, Xinan X; Zhang, Yi Y; Magner, Eamonn E; Lehnert, Erik E; Qian, Chen C; Liu, Jinze J
Publication Date: 2018-10-19

Variant appearance in text: BRAF: a17d
PubMed Link: 30340508
Variant Present in the following documents:
  • 13059_2018_1535_MOESM6_ESM.xlsx, sheet 3
View BVdb publication page



Integrative omics analyses broaden treatment targets in human cancer.

Genome Medicine
Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyö, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L
Publication Date: 2018-07-27

Variant appearance in text: BRAF: A17D
PubMed Link: 30053901
Variant Present in the following documents:
  • 13073_2018_564_MOESM2_ESM.xlsx, sheet 2
View BVdb publication page



BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma.

Pediatric Blood & Cancer
Chisholm, Julia C JC; Suvada, Jozef J; Dunkel, Ira J IJ; Casanova, Michela M; Zhang, Weijiang W; Ritchie, Natasha N; Choi, YounJeong Y; Park, Jane J; Das Thakur, Meghna M; Simko, Stephen S; Wan Rachel Tam, Nga N; Ferrari, Andrea A
Publication Date: 2018-05

Variant appearance in text: BRAF: A17D
PubMed Link: 29350463
Variant Present in the following documents:
  • Main text
View BVdb publication page



Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.

Nature Genetics
Leiserson, Mark D M MD; Vandin, Fabio F; Wu, Hsin-Ta HT; Dobson, Jason R JR; Eldridge, Jonathan V JV; Thomas, Jacob L JL; Papoutsaki, Alexandra A; Kim, Younhun Y; Niu, Beifang B; McLellan, Michael M; Lawrence, Michael S MS; Gonzalez-Perez, Abel A; Tamborero, David D; Cheng, Yuwei Y; Ryslik, Gregory A GA; Lopez-Bigas, Nuria N; Getz, Gad G; Ding, Li L; Raphael, Benjamin J BJ
Publication Date: 2015-02

Variant appearance in text: BRAF: A17D
PubMed Link: 25501392
Variant Present in the following documents:
  • NIHMS644198-supplement-1.pdf
View BVdb publication page